Stanford's Inflammatory Bowel Disease (IBD) Program is nationally recognized for specialized care of patients with Crohn's disease, ulcerative colitis, microscopic colitis and other related diseases. We provide a thorough evaluation and comprehensive management for adults with Inflammatory Bowel Disease and Ulcerative Colitis. As IBD treatment continues to evolve, we are at the forefront of research, including participation in clinical trials for the latest medical breakthroughs in the field of Inflammatory Bowel Disease.
BENEFITS TO YOU
Our IBD Program is nationally recognized. Our research efforts continue to improve therapies and treatment protocols for inflammatory bowel disease.
Our multi-disciplinary treatment approach ensures the development of a comprehensive care plan that maximizes independence and improves quality of life.
Multidisciplinary approach to patient care with team of specialists including gastroenterologists, surgeons, radiologists, pathologists, immunologists, nutritionists, ostomy nurses.
Broad-based knowledge in every area of IBD and Ulcerative Colitis treatment.
Use and development of new diagnostic tools for diagnosing and assessing IBD and Ulcerative Colitis.
Leading therapy directed at improving patient quality of life and incorporating patient's input regarding treatment decisions.
Collaborative novel research with other subspecialties including colorectal surgeons, pediatric gastroenterologists, rheumatologists/immunologists.
Endoscopic procedures for diagnostic purposes: Please see procedures and preparation for more information.